AzTrials
AzTrials

Self-Help DevicesNCT04377893

Applying Eye-Gaze Assistive Technology for Children and Youth With Complex Needs

A study testing Eye gaze AT intervention in people with Self-Help Devices and Eye-Gaze Technology, run by Yu-Hsin Hsieh at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this research is to investigate the impacts of applying eye-gaze assistive technology (AT) in children and youth with severe disabilities and complex needs in Taiwan, where eye-gaze AT has not been researched for children yet. Read more about this study

Who is it for?
Ages 1 year to 25 years
What is being tested?
Eye gaze AT intervention
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
5 participants
Where
1 siteSweden
Study dates
19 Sep 2019to 31 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 25 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Diagnosed with severe physical disability without speaking abilities or with communication difficulties (level III~V on the Communication Function Classification System (CFCS); level IV~V on the Gross Motor Function Classification System (GMFCS) and Manual Ability Classification System (MACS);
  • Children have intentions to communicate using body movement, sounds, facial expressions or others, measured by Communication Matrix (Rowland, 2010) with some emerging skills in level 3;
  • No or limited possibilities to interact with computers using an input method other than EGAT (e.g. switch or touchpads)
  • With access to eye-gazed AT but not used it in daily routines; if possible, new to eye-gaze AT;
  • The parent or the teacher agrees to participate in supporting children to use eye-gaze AT in everyday life during the research period;
  • The therapist who has worked with the child demonstrated motivation to participate in this intervention.

Who cannot join

  • Progressive diseases that caused functional declines, or serious illness

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Department of Special Education, Stockholm University

    Stockholm, Sverige, 10691

Other trials in Sweden

About this study

Official title: Applying Eye-Gaze Assistive Technology in Daily Life for Children and Youth With Severe Physical Disabilities and Complex Communication Needs

The purpose of this research is to investigate the impacts of applying eye-gaze assistive technology (AT) in children and youth with severe disabilities and complex needs in Taiwan, where eye-gaze AT has not been researched for children yet.

Read the detailed description

Background. Children and youth with severe physical disabilities often have concomitant mental impairments and complex needs in communication, and in building relationships with others. The impairments limit their participation and independence in family, school and community life. By using their eyes, the only movements they can control voluntarily, they may increase communication. Relevant research has shown that using eye-gaze AT was feasible for children with severe physical disabilities to make choices, communicate, interact or perform school tasks despite different learning curves. Use of technology may increase opportunities for engagement and self-determination for children and youth with physical disabilities and complex communication needs in family context or in school, but the research is relatively limited. It still needs more studies across countries and long-term follow-up to investigate the effects of the use of eye-gazed AT in life.

Study Aims. There are two aims in this proposed research. Aim 1: To investigate the preliminary effects of eye-gazed AT for daily participation in daily living for children and youth with severe physical disabilities and communication difficulties in Taiwan.

Aim 2: To investigate the adherence of eye-gazed AT intervention for children and youth with severe physical disabilities and communication difficulties, and the caregivers' satisfaction regarding support children and youth to use eye-gazed AT in daily living in Taiwan.

Methods. This study is conducted as a single subject design with multiple baselines across individuals. The inclusions are non-concurrent and the baselines before the intervention started were randomized with unequal of 14-30 days.

This study enrolls participants from Northern Taiwan. The researcher team contacts the practitioners in hospitals, schools or development centers to assist recruitment.

Study procedure. The eye-gaze AT intervention will be conducted for six months and follow up to seven months since provision. Before the intervention started, each of the five participants is randomly assigned to one of the pre-determined baseline lengths (14-30 days).

Repeated measures were conducted in baseline period with a minimum of five data points to judge the stability of the child's abilities and in intervention phase to establish data trends in the levels of two dependent variables, computer usage in daily living (measured by computer use diary along with log data of FocusMe program (FocusMe Inc., London, UK)), and children's activity performance using eye-gaze AT (performance scale of Canadian Occupational Performance Measure (COPM) rated by the parent or teacher). Systematic manipulation of the independent variable, the eye-gaze AT intervention was introduced in the intervention phase. The process was replicated for at least five participants to demonstrate the experiment-control effects.

In addition, other outcomes related to Activity and Participation, Body Functions and Structures and Environmental dimensions based on ICF-CY framework will be collected at baseline, after the 3-month intervention, after the 6-month intervention and 7-month after provision.

Statistical analysis. The visual analysis of single-case data will be used to determine whether there will be a relationship between the independent and dependent variables. The data of continuous variables will be presented as graphs to visually inspected regarding change of data pattern across phases separately.

Due to the small sample size, descriptive statistics will be used to summarize the results of outcome measures and reported using the narrative summary. For COPM, the score change of more than two points is considered clinically significant improvement on both performance and satisfaction scale. Besides, achieving the expected level (0) on a GAS goal is considered successful goal attainment.

Being tested
Eye gaze AT intervention
Keywords
Eye-Gaze Assistive Technology, Severe Physical Disabilities, Communication difficulties
Medical subject headings
Communication Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Eye gaze AT interventionDevice

    The eye-gaze AT intervention includes eye-gaze AT and service delivery to support the participants using this technology in daily life. The Tobii PCEye Mini (Tobii, Danderyd, Sweden) and specialized software are applied with adaptation to meet each child's individual needs.

    To ensure the consistency of service delivery, two-day courses are conducted before the intervention. The participant's teachers or parents are invited as the main interventionist to facilitate the child's usage of eye-gaze AT in daily life under team support. The service delivery involves parents in joint goal-setting, planning, and jointly review the progress of the usage of eye-gaze AT as a family-centered practice. Individual meetings and individual supports are provided during intervention periods. The collaborative team will perform biweekly follow-up contacts during intervention periods.

    The researcher will conduct the fidelity checklist every month to determine the extent of treatment integrity.

Study groups in NCT04377893
Study groupRoleWhat they receive
Treatment armExperimentalParticipants will receive eye-gaze AT intervention
Receives: Device: Eye gaze AT intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Computer Use Diary

    to measure the children´s computer usage in daily living throughout the research period. Parents and teachers observe and document the computer use at home, school and/or center, including duration of use for each activity and type and number of computer activities per day. To increase the reliability of using documentation data from parents or teachers, we will compare with log data from the FocusMe program (FocusMe Inc., London, UK) which monitors the duration and types of app/software the children use eye-gaze AT each time to enhance internal validity.

    Measured: is collected everyday for 8 months.

  2. Changes of Canadian Occupational Performance Measure (COPM)

    to interview the parents or teachers to prioritize goals for daily participation activities using an eye-gazed AT and rate the level of children's performance and satisfaction of children's performance using a 10-point scale (1-10). Higher scores means better performance or higher satisfaction on children's performance.

    Measured: The performance of COPM is monitored twice a week using the proxy ratings by parent or the teacher for 8 months. The satisfaction of COPM is measured at baseline, 3 months and 6 months since intervention provision.

  3. Changes of Goal Attainment Scaling (GAS)

    to evaluate the goals of meaningful use in school and at home with eye-gazed AT. The instrument has five levels of scale values from -2 (starting level) to +2 (more than expected)

    Measured: is collected at 3 months and 6 months since intervention provision.

Secondary outcomes (5)
  1. Communication Matrix

    to evaluate the communicative functions for early communication behaviors through a telephone or face to face interview with proxy persons.

    Measured: is measured at baseline, 3 months and 6 months since intervention provision.

  2. Chinese version of Psychosocial Impact of Assistive Devices Scale (PIADS-C)

    is used to assess the impact of AT on the subjective well-being of end users by proxy persons, including three subscales of competence, adaptability and self-esteem. Each subscale score ranges from -3 to +3, and higher scores indicate better outcomes.

    Measured: is measured at baseline (if the child uses other AT for communication) and after 6-month intervention.

  3. KIDSCREEN-10 parent version

    to evaluate child´s physical, psychological and social well-being. Items are answered on a 5-point Likert-type scale and responses are summed and transformed into T-score with a mean of 50 and a standard deviation of approximately 10. A high score is indicative of a better health-related quality of life.

    Measured: is measured at baseline and after 6-month intervention.

  4. The Taiwanese Version of Quebec User Evaluation of Satisfaction with Assistive Technology (T- QUEST)

    to evaluate parents' and teachers' satisfaction with the eye-gazed AT as an assistive device and with the service provided related to the eye-gazed AT. Each item ranges from 1 "Not satisfied at all" to 5 "Very satisfied." Higher values represent higher satisfaction.

    Measured: is measured after 6-month intervention.

  5. COMPASS Aim test

    to measure the eye gaze performance (time on task and accuracy) with the eye-gazed AT.

    Measured: Five trials with 12 targets in each trial will be conducted at baseline, 3 months and 6 months since intervention provision.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2020
  2. Study start19 Sep 2019
  3. Primary completion31 Jul 2020
  4. Study completion31 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
5 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04377893
Sponsor's protocol ID
CGUSU180116
Status last verified
Sep 2021
First submitted
22 Apr 2020
Last updated
27 Sep 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hsieh YH, Granlund M, Odom SL, Hwang AW, Hemmingsson H. Increasing participation in computer activities using eye-gaze assistive technology for children with complex needs. Disabil Rehabil Assist Technol. 2024 Feb;19(2):492-505. doi: 10.1080/17483107.2022.2099988. Epub 2022 Jul 21.

    PubMed 35861506

Questions about this trial

What is this clinical trial studying?

A study testing Eye gaze AT intervention in people with Self-Help Devices and Eye-Gaze Technology, run by Yu-Hsin Hsieh at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Computer Use Diary (time frame: is collected everyday for 8 months.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04377893, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Sep 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in